Verici Dx (LON:VRCI) Trading Down 12% – Should You Sell?

Verici Dx plc (LON:VRCI)’s share price was down 12% during trading on Thursday . The company traded as low as GBX 0.55 and last traded at GBX 0.55. Approximately 360,247 shares were traded during trading, a decline of 75% from the average daily volume of 1,425,193 shares. The stock had previously closed at GBX 0.63.

Verici Dx Trading Down 5.6%

The company’s fifty day moving average is GBX 0.71 and its two-hundred day moving average is GBX 0.69. The stock has a market cap of £8.93 million, a price-to-earnings ratio of -0.20 and a beta of 1.59. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.